T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor
Charly Le Maout, Lucine Fahy, Laurent Renou, Caroline Devanand, Charlotte Duwat, Vilma Barroca, Morgane Le Gall, Paola Fabiola Ballerini, Arnaud Petit, Julien Calvo, Benjamin Uzan, Françoise Pflumio, Vanessa Petit
This study identifies an inflammatory microenvironment in T-ALL that supports progression, with HGF as a potential therapeutic target.
Biomedicine & Pharmacotherapy · Jul 1, 2024Peer-reviewedCancer Biology